| Pharmaceutical Information |
| Drug Name |
Kanamycin |
| Drug ID |
BADD_D01226 |
| Description |
Kanamycin (also known as kanamycin A) is an aminoglycoside bacteriocidal antibiotic, available in oral, intravenous, and intramuscular forms, and used to treat a wide variety of infections. Kanamycin is isolated from the bacterium Streptomyces kanamyceticus and its most commonly used form is kanamycin sulfate. |
| Indications and Usage |
For treatment of infections where one or more of the following are the known or suspected pathogens: E. coli, Proteus species (both indole-positive and indole-negative), E. aerogenes, K. pneumoniae, S. marcescens, and Acinetobacter species. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
A07AA08; J01GB04; S01AA24 |
| DrugBank ID |
DB01172
|
| KEGG ID |
C00304
|
| MeSH ID |
D007612
|
| PubChem ID |
6032
|
| TTD Drug ID |
D0YV1Q
|
| NDC Product Code |
Not Available |
| Synonyms |
Kanamycin | Kantrex | Kanamycin A | Kanamycin Sulfate |
|
| Chemical Information |
| Molecular Formula |
C18H36N4O11 |
| CAS Registry Number |
59-01-8 |
| SMILES |
C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
